Liposomal Anthracyclines in the Management of Patients with HIV-Positive Kaposi’s Sarcoma

A clinical practice guideline for patients with HIV-positive Kaposi’s sarcoma. The guideline examines the use of liposomal anthracycline therapy in aggressive cutaneous or visceral disease sites and comparisons are made to combination chemotherapy. Outcomes of interest include no significant differences between liposomal therapy and conventional combination therapy.